gingerenone a

**Gingerenone a** is a small molecule polyphenol isolated from ginger (*Zingiber officinale*). It has demonstrated selective **senolytic** activity, promoting the death of senescent (aging) cells without harming non-senescent cells, which may have therapeutic potential for diseases characterized by senescent cell accumulation, such as age-related disorders[1][2][6]. Mechanistically, gingerenone a suppresses the senescence-associated secretory phenotype (SASP), reducing pro-inflammatory cytokines (e.g., IL-6, CCL2, IP-10) and increasing anti-inflammatory cytokines (e.g., IL-10, IL-13), but can also increase some pro-inflammatory markers (IL-8, IL-1β)[1]. It induces apoptosis in senescent cells via increased caspase-3 activity and reduced expression of the anti-apoptotic protein Bcl-XL, independently of p53[1][9]. Gingerenone a is also reported to activate the Nrf2-Gpx4 pathway, which may contribute to its anti-inflammatory, anti-cancer, and ferroptosis-inducing effects[3][7][10]. Additionally, it has been identified as an inhibitor of p70 S6 kinase (S6K1), which plays a role in insulin resistance[8][10]. Preclinical studies highlight its potential in cancer (liver, breast), inflammation, and metabolic disease, but human therapeutic use remains unproven[1][2][6].

Other names

gin agingerenone a